Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 28 (4) , 577-583
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01CA190542, R21AI124049)
This publication has 21 references indexed in Scilit:
- Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and SelectivityACS Chemical Biology, 2016
- The Role of Protein Loops and Linkers in Conformational Dynamics and AllosteryChemical Reviews, 2016
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexesPharmacological Research, 2016
- Protein Phosphorylation: A Major Switch Mechanism for Metabolic RegulationTrends in Endocrinology & Metabolism, 2015
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)Journal of Medicinal Chemistry, 2011
- Evolution of domain combinations in protein kinases and its implications for functional diversityProgress in Biophysics and Molecular Biology, 2010
- Mechanisms of specificity in protein phosphorylationNature Reviews Molecular Cell Biology, 2007
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- Regulation of Protein KinasesMolecular Cell, 2004
- A template for the protein kinase familyTrends in Biochemical Sciences, 1993